Tag: pegfp n3
Targeting CD99 compromises the oncogenic effects of the chimera EWS-FLI1 by inducing re-expression of zyxin and inhibition of Gli1 activity
Ewing sarcoma (EWS), a highly aggressive pediatric tumor, is driven by EWS-FLI1, an oncogenic transcription factor that remodels the tumor genetic landscape. Epigenetic mechanisms play a pivotal role in EWS pathogenesis, and the therapeutic value of compounds targeting epigenetic pathways is being identified in preclinical models. Here we showed that modulation of CD99, a cell…Read More
The effect of glycosylation on the antibody recognition of a MUC2 mucin epitope.
MUC2 glycoprotein, produced by the epithelium of the colon and constructed up primarily of repeat items of (1) PTTTPITTTTTVTPTPTPTGTQT(23) , could be overexpressed or underglycosylated in gastrointestinal illnesses, e.g. in case of colon carcinoma. We have now been finding out the epitope construction of the MUC2 by specializing in the repeat unit with the mucin…Read More